tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Aurinia Pharmaceuticals Inc

AUPH
Add to Watchlist
14.880USD
-0.120-0.80%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.91BMarket Cap
6.68P/E TTM

Aurinia Pharmaceuticals Inc

14.880
-0.120-0.80%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

AUPH Financials

See Aurinia Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Aurinia Pharmaceuticals Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
0.26/0.20
Revenue / Forecast
77.70M/77.39M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
283.06M
20.38%
EPS(YoY)
2.14
5215.69%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
54.45%0.26
15792.34%1.60
138.63%0.24
3064.88%0.16
325.13%0.17
105.37%0.01
206.55%0.10
106.26%0.01
59.37%-0.07
-2.09%-0.19
---0.09
---0.08
---0.18
---0.18
---0.58
----
----
----
----
----
Revenue
24.40%77.70M
28.81%77.11M
8.41%73.47M
22.41%70.01M
24.18%62.47M
32.76%59.87M
24.32%67.77M
37.83%57.19M
46.19%50.30M
58.59%45.09M
-2.27%54.52M
47.19%41.49M
59.12%34.41M
21.50%28.43M
280.30%55.78M
325.85%28.19M
2265.97%21.63M
--23.40M
50475.86%14.67M
22727.59%6.62M
Net Profit
47.17%34.35M
14651.15%210.79M
119.87%31.55M
2879.64%21.51M
317.17%23.34M
105.32%1.43M
206.72%14.35M
106.28%722.00K
58.98%-10.75M
-3.18%-26.88M
-49.59%-13.45M
67.64%-11.49M
30.36%-26.21M
21.84%-26.05M
82.11%-8.99M
24.45%-35.52M
25.31%-37.63M
---33.32M
-19.29%-50.26M
-77.10%-47.01M
Net Margin
18.30%44.21%
11351.96%273.35%
102.82%42.95%
2334.18%30.73%
274.89%37.37%
104.01%2.39%
185.84%21.17%
104.56%1.26%
71.94%-21.37%
34.94%-59.60%
---24.67%
---27.70%
---76.16%
---91.60%
---77.78%
----
----
----
----
----
Gross Margin
6.21%91.63%
-2.35%88.59%
-2.44%88.87%
6.41%89.84%
1.99%86.27%
3.06%90.73%
4.01%91.10%
-12.27%84.42%
-14.36%84.59%
-7.53%88.04%
--87.58%
--96.23%
--98.78%
--95.21%
--95.93%
----
----
----
----
----
Debt to assets ratio
-36.76%8.94%
-30.53%9.16%
-7.25%13.66%
-0.29%15.01%
-10.10%14.13%
-19.79%13.18%
-4.45%14.72%
-11.55%15.06%
--15.72%
--16.44%
--15.41%
--17.02%
----
----
----
----
----
----
----
----
Income Statement
Revenue
24.40%77.70M
28.81%77.11M
8.41%73.47M
22.41%70.01M
24.18%62.47M
32.76%59.87M
24.32%67.77M
37.83%57.19M
46.19%50.30M
58.59%45.09M
-2.27%54.52M
47.19%41.49M
59.12%34.41M
21.50%28.43M
280.30%55.78M
325.85%28.19M
2265.97%21.63M
--23.40M
50475.86%14.67M
22727.59%6.62M
Operating profit
77.17%41.42M
142.94%33.24M
153.19%29.75M
4679.82%20.20M
455.86%23.38M
146.11%13.68M
172.24%11.75M
97.27%-441.00K
77.79%-6.57M
-5.60%-29.67M
-71.21%-16.26M
55.07%-16.17M
21.90%-29.58M
14.08%-28.10M
81.14%-9.50M
23.65%-35.99M
25.05%-37.88M
---32.70M
-19.00%-50.35M
-75.46%-47.13M
Net Profit
47.17%34.35M
14651.15%210.79M
119.87%31.55M
2879.64%21.51M
317.17%23.34M
105.32%1.43M
206.72%14.35M
106.28%722.00K
58.98%-10.75M
-3.18%-26.88M
-49.59%-13.45M
67.64%-11.49M
30.36%-26.21M
21.84%-26.05M
82.11%-8.99M
24.45%-35.52M
25.31%-37.63M
---33.32M
-19.29%-50.26M
-77.10%-47.01M
Balance Sheet
Current assets
18.36%480.24M
10.16%491.97M
-0.39%438.74M
-0.17%408.97M
1.89%405.76M
5.13%446.60M
3.28%440.46M
-1.50%409.67M
-6.00%398.22M
-4.01%424.80M
-7.23%426.47M
-8.23%415.91M
-11.30%423.65M
-13.79%442.54M
39.63%459.70M
29.60%453.19M
28.31%477.62M
22.39%513.32M
-18.78%329.22M
25.77%349.69M
Total current liabilities
26.53%86.56M
-4.13%93.72M
-3.04%76.22M
1.77%78.27M
-3.72%68.41M
26.66%97.76M
6.39%78.61M
24.72%76.90M
68.99%71.05M
67.41%77.19M
76.92%73.89M
78.08%61.66M
24.26%42.05M
13.44%46.11M
11.26%41.77M
18.12%34.63M
59.98%33.84M
27.03%40.65M
54.43%37.54M
65.07%29.32M
Total assets
43.41%724.00M
36.49%751.59M
-3.97%527.53M
-4.00%502.56M
-2.28%504.85M
0.47%550.64M
-1.02%549.36M
-4.62%523.53M
14.36%516.63M
16.40%548.06M
13.66%555.01M
13.84%548.90M
-10.88%451.76M
-13.34%470.86M
35.61%488.29M
24.82%482.15M
21.54%506.90M
17.19%543.37M
-20.53%360.07M
31.64%386.27M
Total liabilities
1.11%156.37M
-1.68%170.26M
0.25%161.76M
5.25%167.26M
-1.59%154.66M
1.80%173.17M
-1.09%161.36M
1.47%158.91M
156.15%157.16M
160.00%170.11M
151.49%163.14M
168.26%156.61M
4.38%61.35M
1.79%65.42M
4.80%64.87M
8.09%58.38M
25.46%58.78M
14.96%64.28M
41.88%61.89M
51.15%54.01M
Total equity
62.09%567.63M
54.00%581.33M
-5.73%365.77M
-8.04%335.30M
-2.58%350.19M
-0.13%377.48M
-0.99%388.00M
-7.05%364.62M
-7.92%359.48M
-6.78%377.95M
-7.45%391.88M
-7.43%392.29M
-12.88%390.41M
-15.37%405.44M
42.01%423.43M
27.54%423.77M
21.04%448.12M
17.50%479.09M
-27.17%298.17M
28.93%332.26M
Cash Flow Statement
Net operating income
2404.62%32.56M
51.65%45.67M
161.02%44.45M
179.25%44.24M
106.99%1.30M
110.41%30.11M
228.26%17.03M
660.62%15.84M
41.28%-18.60M
36.96%14.31M
13.57%-13.28M
89.86%-2.83M
32.25%-31.67M
140.31%10.45M
61.83%-15.36M
26.61%-27.87M
12.69%-46.75M
---25.92M
-41.65%-40.25M
-72.33%-37.98M
Net investment
-158.26%-18.08M
-193.71%-36.76M
-30.27%-13.77M
65.63%-13.27M
-36.97%31.03M
726.87%39.22M
46.34%-10.57M
-588.69%-38.62M
98.04%49.23M
-107.32%-6.26M
60.77%-19.70M
-112.29%-5.61M
146.89%24.86M
45.00%-3.02M
-53.08%-50.22M
2631.80%45.62M
21.16%-53.02M
---5.49M
77.30%-32.81M
108.06%1.67M
Net financing
-8.81%-53.69M
91.80%-1.89M
-285.38%-10.49M
-436.61%-44.39M
-227.80%-49.34M
-313.23%-23.05M
-16.72%-2.72M
-825.70%-8.27M
-1018.30%-15.05M
-910.61%-5.58M
---2.33M
-14.93%1.14M
304.69%1.64M
-99.67%688.00K
-100.00%0.00
4.77%1.34M
-91.95%405.00K
--205.72M
-95.20%9.08M
34.07%1.28M

FAQs

What is the total revenue of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 283.06M, with a year-on-year change of 235.13M.

What are the current assets of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its current assets were 491.97M, with a year-on-year change of 10.16.

What are the total assets of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its total assets of Aurinia Pharmaceuticals Inc were 751.59M, with a year-on-year change of 36.49.

What are the total liabilities of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Aurinia Pharmaceuticals Inc were 170.26M, with a year-on-year change of -1.68.

What is the total equity of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its total equity of Aurinia Pharmaceuticals Inc was 581.33M, with a year-on-year change of 54.00.

What is the net operating income of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Aurinia Pharmaceuticals Inc was 106.56M, with a year-on-year change of 478.54.

What is the net investment of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its net investment of Aurinia Pharmaceuticals Inc was -32.77M, with a year-on-year change of -183.46.

What is the net financing of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its net financing of Aurinia Pharmaceuticals Inc was -106.11M, with a year-on-year change of -116.15.

What is the Earnings Per Share (EPS) of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 2.14, with a year-on-year change of 5215.69.

What is the net income of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its net income was 287.20M, with a year-on-year change of 4893.08.

What is the net margin of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 101.47, with a year-on-year change of 4047.75.

What is the gross margin of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 88.46, with a year-on-year change of 0.54.

What is the debt-to-asset ratio of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 9.16, with a year-on-year change of -30.53.

What is the Return on Equity (ROE) of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was 59.91, with a year-on-year change of 3833.98.

What is the Return on Assets (ROA) of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 44.11, with a year-on-year change of 4112.72.

What is the operating profit of Aurinia Pharmaceuticals Inc?

According to Aurinia Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 106.56M, with a year-on-year change of 478.54.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy